Overview

The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults.

Status:
Completed
Trial end date:
2019-11-26
Target enrollment:
Participant gender:
Summary
This is a Phase 1, open-label, fixed-sequence, 3-period, 2-way drug interaction study designed to assess the PK, PD, safety, and tolerability of LC350189 and colchicine when administered alone and in combination in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
LG Chem
Treatments:
Colchicine